In our study, complement C3, C4, and fibrinogen were proteins that differentiated the group of T1DM patients into subgroups with good (HbA1c < 7%) and poor (HbA1c > 7%) metabolic control and the occurrence of complications. The gene discussed is C4A; the disease is type 1 diabetes mellitus.